Ahammune Biosciences

About:

Ahammune Biosciences is an innovation-led drug discovery company.

Top Investors: IAN Group, Survam Partners, Capital 2B, Pi Ventures, Ideaspring Capital

Description:

Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo.

Total Funding Amount:

$5M

Headquarters Location:

Pune, Maharashtra, India

Founded Date:

2016-01-01

Contact Email:

info(AT)ahammune.com

Founders:

Parul Ganju

Number of Employees:

1-10

Last Funding Date:

2024-09-25

IPO Status:

Private

Industries: